CN103316291A - Anti acne of traditional Chinese medicine - Google Patents

Anti acne of traditional Chinese medicine Download PDF

Info

Publication number
CN103316291A
CN103316291A CN2013102301526A CN201310230152A CN103316291A CN 103316291 A CN103316291 A CN 103316291A CN 2013102301526 A CN2013102301526 A CN 2013102301526A CN 201310230152 A CN201310230152 A CN 201310230152A CN 103316291 A CN103316291 A CN 103316291A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
acne
crude drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013102301526A
Other languages
Chinese (zh)
Other versions
CN103316291B (en
Inventor
李秀琴
张辉
马燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Junda Biological Polytron Technologies Inc
Original Assignee
TAICANG SIRUI BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAICANG SIRUI BIOTECHNOLOGY Co Ltd filed Critical TAICANG SIRUI BIOTECHNOLOGY Co Ltd
Priority to CN201310230152.6A priority Critical patent/CN103316291B/en
Publication of CN103316291A publication Critical patent/CN103316291A/en
Application granted granted Critical
Publication of CN103316291B publication Critical patent/CN103316291B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to an anti acne traditional Chinese medicine that comprises, in parts by weight, 2-4 parts of licorice, 2-4 parts of white peony root, 1.5-2 parts of shepherd's purse, 1-1.5 parts of curcuma tuber, and 1-1.5 parts of albizia bark. The advantages of the invention reside in that a novel anti acne medicament is provided, which has substantial and stable effect to acne treatment; a few kinds of medicament are provided and they all are normal traditional Chinese medicine; the preparation technology is simple, and the medicament has rapid effect, short treatment course and very low cost, therefore the pressure of payment is greatly reduced; and the medicament has no toxic and side-effect, can be widely promoted.

Description

A kind of anti-acne Chinese medicine
Technical field
The present invention relates to technical field of Chinese medicines, specifically, is a kind of anti-acne Chinese medicine.
Background technology
Anti-acne is to use Medical Technology or method to eliminate the process of comedo; Pox is being commonly called as of acne, is again " comedo ", " skin sore " or " acne ", is because a kind of dermatosis that hair follicle and sebaceous gland are blocked, inflammation causes.During adolescence, the hormone meeting stimulating hair growth in the body promotes more heavy wool fat of smegma, and therefore hair and sebaceous gland pile up many materials, make oils and fats and bacterial adhesion, cause the reaction of red swelling of the skin.Because this symptom is common in youth of both sexes, so claim that just it is " comedo ".In fact, teenager not necessarily all can long comedo, and comedo is also not necessarily only long with it teen-age.
At present the Chinese and western medicine externally applied ointment to the treatment of acne for taking stopgap measures, and that the deficiency of oral medicine integrative therapy is relapse rate is high, untoward reaction is many, medical expense is high, oral medicine Chinese traditional treatment acne has obtained certain effect, but existing medicine is laid particular stress on unilaterally mostly, and universality is not strong, DeGrain, and the flavour of a drug number is more, treatment cycle is long, there is no so far a kind of generally applicablely, and can fundamentally cure the medicine of acne.
Summary of the invention
The objective of the invention is for deficiency of the prior art, a kind of anti-acne Chinese medicine is provided.
Again one purpose of the present invention is that another kind of anti-acne Chinese medicine is provided.
Another purpose of the present invention is that a kind of application of anti-acne Chinese medicine is provided.
For achieving the above object, the technical scheme that the present invention takes is: a kind of anti-acne Chinese medicine, made by the crude drug of following weight portion: Radix Glycyrrhizae 2-4 part, Radix Paeoniae Alba 2-4 part, Herba Capsellae 1.5-2 part, Radix Curcumae 1-1.5 part, Cortex Albiziae 1-1.5 part.
Preferably made by the crude drug of following weight portion: 2 parts in Radix Glycyrrhizae, 2 parts of the Radix Paeoniae Albas, 1.5 parts in Herba Capsellae, 1 part of Radix Curcumae, 1.5 parts of Cortex Albiziaes.
Preferably made by the crude drug of following weight portion: 3 parts in Radix Glycyrrhizae, 3 parts of the Radix Paeoniae Albas, 1.8 parts in Herba Capsellae, 1.2 parts of Radix Curcumaes, 1.2 parts of Cortex Albiziaes.
Preferably made by the crude drug of following weight portion: 4 parts in Radix Glycyrrhizae, 4 parts of the Radix Paeoniae Albas, 2 parts in Herba Capsellae, 1.5 parts of Radix Curcumaes, 1 part of Cortex Albiziae.
For realizing above-mentioned second purpose, the technical scheme that the present invention takes is: a kind of anti-acne Chinese medicine, made by the crude drug of following weight portion: 3 parts in Radix Glycyrrhizae, 3 parts of the Radix Paeoniae Albas, 1.8 parts in Herba Capsellae, 1.2 parts of Radix Curcumaes, 1.2 parts of Cortex Albiziaes, 1 part of Fructus Crataegi, 2 parts of Caulis Sinomeniis, 1 part of Radix Angelicae Sinensis, 1 part of Rhizoma Atractylodis, 2 parts of the Radixs Angelicae Dahuricae, 2 parts in Herba Ephedrae, 1.5 parts of Sargassums, 2 parts of Radix Codonopsis, 1 part of the Rhizoma Atractylodis Macrocephalae, 1.5 parts in the Radix Rehmanniae, 2 parts of Radix Notoginseng, 3 parts of Rhizoma Fagopyri Dibotryiss.
For realizing above-mentioned the 3rd purpose, the technical scheme that the present invention takes is: the application of described Chinese medicine in preparation anti-acne medicine or health product.
The invention has the advantages that:
1, a kind of novel drugs of anti-acne is provided, for Acne treatment very remarkable and stable effect has been arranged;
2, the flavour of a drug number is less, and all is conventional Chinese medicine, and preparation technology is also very simple, rapid-action, and short treating period, cost are extremely low, greatly reduce patient's burden;
3, have no side effect, be suitable for extensive popularization.
The specific embodiment
Below in conjunction with embodiment the specific embodiment provided by the invention is elaborated.
Embodiment 1
2 parts in Radix Glycyrrhizae, 2 parts of the Radix Paeoniae Albas, 1.5 parts in Herba Capsellae, 1 part of Radix Curcumae, 1.5 parts of Cortex Albiziaes.Conventional method decocts into decoction.
Embodiment 2
3 parts in Radix Glycyrrhizae, 3 parts of the Radix Paeoniae Albas, 1.8 parts in Herba Capsellae, 1.2 parts of Radix Curcumaes, 1.2 parts of Cortex Albiziaes.Conventional method decocts into decoction.
Embodiment 3
4 parts in Radix Glycyrrhizae, 4 parts of the Radix Paeoniae Albas, 2 parts in Herba Capsellae, 1.5 parts of Radix Curcumaes, 1 part of Cortex Albiziae.Conventional method decocts into decoction.
Embodiment 4
2.5 parts in Radix Glycyrrhizae, 2.5 parts of the Radix Paeoniae Albas, 1.6 parts in Herba Capsellae, 1.3 parts of Radix Curcumaes, 1.3 parts of Cortex Albiziaes.Conventional method decocts into decoction.
Embodiment 5
3.5 parts in Radix Glycyrrhizae, 3.5 parts of the Radix Paeoniae Albas, 1.9 parts in Herba Capsellae, 1.3 parts of Radix Curcumaes, 1.3 parts of Cortex Albiziaes.Conventional method decocts into decoction.
Embodiment 6 clinical experiments
1. case is selected
Facial acne vulgaris patient 60 examples have typical clinical manifestation, meet the diagnostic criteria of acne vulgaris, comedo, do not make any Drug therapy in one month, without merging other diseases.Be divided at random two groups, two groups of state of an illness, age etc. have comparability without significant difference.
Test group: take the Chinese medicine decoction (containing crude drug amount 1.0g/mL) according to embodiment 2 preparations, sooner or later respectively once, and each 200mL, 7 days is a course for the treatment of, takes altogether 4 courses for the treatment of.
Matched group: take the decocting for Chinese herbal medicine liquid (containing crude drug amount 1.0g/mL) according to the preparation of embodiment 2 methods, wherein do not contain Herba Capsellae in the raw material of Chinese medicine medicine, i.e. 3 parts in Radix Glycyrrhizae, 3 parts of the Radix Paeoniae Albas, 1.2 parts of Radix Curcumaes, 1.2 parts of Cortex Albiziaes.Sooner or later respectively once, each 200mL, 7 days is a course for the treatment of, takes altogether 4 courses for the treatment of.
2. evaluation criterion
Produce effects: the healing of facial area acne, without new red pimple, clinical symptom disappearance.
Effectively: the facial area acne heals substantially, and without new red pimple, clinical symptoms disappears substantially.
Invalid: as without obviously changing, to still have new red pimple before facial area acne and clinical symptoms and the treatment.
3. efficacy result
See the following form 1.Efficacy result shows, anti-acne Chinese medicine of the present invention has significant therapeutic effect to acne, and is not only rapid-action, and the 1st all effective percentage just reach 83.3%, and cure rate is high, reaches especially 100% effective percentage after treating for 4 weeks.Although other four Chinese medicines of matched group are identical with the test group proportion of composing, but owing to not adding Herba Capsellae, curative effect is had a greatly reduced quality, effective percentage just reaches 43.3% after 4 weeks for the treatment of, Herba Capsellae there is no the report of Acne treatment clinically, but curative effect of medication demonstration of the present invention, Herba Capsellae and other four Chinese medicines of the present invention share and have shown very strong synergism, so that the present invention can effectively cure acne.All do not find untoward reaction for two groups.
Table 1 efficacy result
Figure 2013102301526100002DEST_PATH_IMAGE001
Also added up respectively the therapeutic effect that adopts respectively the ratio of embodiment 1-5 in the test, after 4 weeks for the treatment of, effective percentage is respectively 91%, 100%, 92%, 85%, 80%, and the result shows, the crude drug proportioning therapeutic effect of embodiment 3 is best, secondly is embodiment 1 and 2.
Embodiment 7
The inventor is in process of the test, also investigated another more prescription of flavour of a drug number, that is: 3 parts in Radix Glycyrrhizae, 3 parts of the Radix Paeoniae Albas, 1.8 parts in Herba Capsellae, 1.2 parts of Radix Curcumaes, 1.2 parts of Cortex Albiziaes, 1 part of Fructus Crataegi, 2 parts of Caulis Sinomeniis, 1 part of Radix Angelicae Sinensis, 1 part of Rhizoma Atractylodis, 2 parts of the Radixs Angelicae Dahuricae, 2 parts in Herba Ephedrae, 1.5 parts of Sargassums, 2 parts of Radix Codonopsis, 1 part of the Rhizoma Atractylodis Macrocephalae, 1.5 parts in the Radix Rehmanniae, 2 parts of Radix Notoginseng, 3 parts of Rhizoma Fagopyri Dibotryiss.Take the Chinese medicine decoction (containing crude drug amount 1.0g/mL) of conventional method preparation, sooner or later respectively once, each 200mL, 7 days is a course for the treatment of, takes altogether 4 courses for the treatment of.
Result of the test shows, this Chinese medicinal formulae also can reach 100% effective percentage after 4 weeks, and compare the prescription proportioning of embodiment 2, the patient who adopts the former prescription not only acne has obtained healing, face scar also obviously subtracts light (70%), also has simultaneously part whitening effect (60%), although show that this prescription flavour of a drug number is more, but not only have good acne treatment effect, also have the effect of desalination cicatrix and whitening concurrently.

Claims (6)

1. an anti-acne Chinese medicine is characterized in that, is made by the crude drug of following weight portion: Radix Glycyrrhizae 2-4 part, Radix Paeoniae Alba 2-4 part, Herba Capsellae 1.5-2 part, Radix Curcumae 1-1.5 part, Cortex Albiziae 1-1.5 part.
2. Chinese medicine according to claim 1 is characterized in that, is made by the crude drug of following weight portion: 2 parts in Radix Glycyrrhizae, 2 parts of the Radix Paeoniae Albas, 1.5 parts in Herba Capsellae, 1 part of Radix Curcumae, 1.5 parts of Cortex Albiziaes.
3. Chinese medicine according to claim 1 is characterized in that, is made by the crude drug of following weight portion: 3 parts in Radix Glycyrrhizae, 3 parts of the Radix Paeoniae Albas, 1.8 parts in Herba Capsellae, 1.2 parts of Radix Curcumaes, 1.2 parts of Cortex Albiziaes.
4. Chinese medicine according to claim 1 is characterized in that, is made by the crude drug of following weight portion: 4 parts in Radix Glycyrrhizae, 4 parts of the Radix Paeoniae Albas, 2 parts in Herba Capsellae, 1.5 parts of Radix Curcumaes, 1 part of Cortex Albiziae.
5. anti-acne Chinese medicine, it is characterized in that, made by the crude drug of following weight portion: 3 parts in Radix Glycyrrhizae, 3 parts of the Radix Paeoniae Albas, 1.8 parts in Herba Capsellae, 1.2 parts of Radix Curcumaes, 1.2 parts of Cortex Albiziaes, 1 part of Fructus Crataegi, 2 parts of Caulis Sinomeniis, 1 part of Radix Angelicae Sinensis, 1 part of Rhizoma Atractylodis, 2 parts of the Radixs Angelicae Dahuricae, 2 parts in Herba Ephedrae, 1.5 parts of Sargassums, 2 parts of Radix Codonopsis, 1 part of the Rhizoma Atractylodis Macrocephalae, 1.5 parts in the Radix Rehmanniae, 2 parts of Radix Notoginseng, 3 parts of Rhizoma Fagopyri Dibotryiss.
6. the application of the described Chinese medicine of claim 1-5 in preparation anti-acne medicine or health product.
CN201310230152.6A 2013-06-09 2013-06-09 Anti acne of traditional Chinese medicine Expired - Fee Related CN103316291B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310230152.6A CN103316291B (en) 2013-06-09 2013-06-09 Anti acne of traditional Chinese medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310230152.6A CN103316291B (en) 2013-06-09 2013-06-09 Anti acne of traditional Chinese medicine

Publications (2)

Publication Number Publication Date
CN103316291A true CN103316291A (en) 2013-09-25
CN103316291B CN103316291B (en) 2015-05-27

Family

ID=49185524

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310230152.6A Expired - Fee Related CN103316291B (en) 2013-06-09 2013-06-09 Anti acne of traditional Chinese medicine

Country Status (1)

Country Link
CN (1) CN103316291B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106110188A (en) * 2016-07-20 2016-11-16 韩光泉 A kind of anti acne of traditional Chinese medicine
CN107308405A (en) * 2017-06-23 2017-11-03 禹州市合同泰药业有限公司 A kind of anti-acne is except scar pill and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
南京中医药大学: "《中药大辞典》", 31 March 2006, 上海科学技术出版社 *
方亚雯,等: "李映琳辨证论治痤疮经验举隅", 《北京中医药》 *
魏辉: "名老中医治疗痤疮的经验探析", 《陕西中医》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106110188A (en) * 2016-07-20 2016-11-16 韩光泉 A kind of anti acne of traditional Chinese medicine
CN107308405A (en) * 2017-06-23 2017-11-03 禹州市合同泰药业有限公司 A kind of anti-acne is except scar pill and preparation method thereof

Also Published As

Publication number Publication date
CN103316291B (en) 2015-05-27

Similar Documents

Publication Publication Date Title
CN101461921B (en) Medicinal composition for treating gynecopathy
CN101002848B (en) Medicine for treating recurrent uarthritis, and its preparing method
CN103316291B (en) Anti acne of traditional Chinese medicine
CN103919966B (en) A kind of medicine treating acne
CN101130052A (en) Traditional Chinese medicine for treating post partum paralysis
CN102657785A (en) Medicinal composition for treating gingivitis
CN102697984B (en) Chinese medicinal external application preparation for treating acute mastitis
CN102038799B (en) Application of breast lump-elimination preparation in preparing medicines for treating dysmenorrhea
CN103330909B (en) A kind of pure Chinese medicine anti-acne medicine
CN103316294B (en) Be used for the treatment of the pharmaceutical composition of acne
CN103330910B (en) A kind of Chinese medicine is for the preparation of the medicine of anti-acne and health product
CN102579678B (en) Medicinal composition for treating vitligo
CN103316293B (en) A kind of Chinese prescription is for the preparation of the purposes of anti-acne medicine
CN103316292A (en) Traditional Chinese medicine composition for treatment of acne vulgaris
CN102078432A (en) Medicament for treating skin itch
CN104435545A (en) Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning
CN101244181B (en) Plaster for bone paralysis with function of qufengshengshi, blood circulation activating and stasis removing, and removing the obstruction in the channels to relieve pain, and preparation thereof
CN103585545A (en) Traditional Chinese medicine composition for treating otitis media
CN103860869A (en) Traditional Chinese medicine for treating gestational hypertension
CN103751418A (en) Traditional Chinese medicine composition for treating restless leg syndrome
CN103006995B (en) Medicine for treating post-dural puncture headache (PDPHA)
CN103341100A (en) Medicinal liquor for activating blood, relieving pain, resisting inflammation and diminishing swelling
CN103239646B (en) Chinese medicine effective part composition for treating leucoderma and preparation method thereof
CN102423367B (en) Beautifying and blood-activating medicament
CN115770279B (en) Traditional Chinese medicine composition for treating chronic lower limb vein diseases, decoction and preparation thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: GUANGDONG SANJIU JUNDA BIOTECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: TAICANG SIRUI BIOTECHNOLOGY CO., LTD.

Effective date: 20150703

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20150703

Address after: 510000 Guangdong city of Guangzhou province with the international business center and Cloud View Garden Yun Feng building 3

Patentee after: SANJIU JUNDA BIOTECHNOLOGY CO.,LTD. GUANGDONG PROVINCE

Address before: 111, room 8-6, building 2, middle Xingang Road, Taicang Port Development Zone, Suzhou, Jiangsu,

Patentee before: TAICANG SIRUI BIOLOGICAL SCIENCE & TECHNOLOGY CO.,LTD.

C56 Change in the name or address of the patentee
CP03 Change of name, title or address

Address after: Evelyn Lu Yun Chia Street Baiyun District of Guangzhou City, Guangdong province 510000 No. 4 room 313

Patentee after: In the 39 Guangdong biological Polytron Technologies Inc.

Address before: 510000 Guangdong city of Guangzhou province with the international business center and Cloud View Garden Yun Feng building 3

Patentee before: SANJIU JUNDA BIOTECHNOLOGY CO.,LTD. GUANGDONG PROVINCE

CP01 Change in the name or title of a patent holder

Address after: Evelyn Lu Yun Chia Street Baiyun District of Guangzhou City, Guangdong province 510000 No. 4 room 313

Patentee after: Guangdong Junda biological Polytron Technologies Inc.

Address before: Evelyn Lu Yun Chia Street Baiyun District of Guangzhou City, Guangdong province 510000 No. 4 room 313

Patentee before: In the 39 Guangdong biological Polytron Technologies Inc.

CP01 Change in the name or title of a patent holder
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150527

CF01 Termination of patent right due to non-payment of annual fee